Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

Author： Birjmohun R. S. Kastelein J. J. P. Poldermans D. Stroes E. S. G Hostalek U. Assmann G.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.7, 2007-07, pp. : 1707-1713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study

By Vogt A. Kassner U. Hostalek U. Steinhagen-Thiessen E.

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 417-425

Informa Healthcare

Access to resources Recommend Favorite

Influence of the timing of low-dose aspirin on tolerability of prolonged-release nicotinic acid in patients at elevated cardiovascular risk

By Delgado Alves J. Steinhagen-Thiessen E. Darioli R. Hostalek U. Vogt A.

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2815-2820

Informa Healthcare

Access to resources Recommend Favorite

Determinants of CRP level in statin-treated patients

By Liem A. H. van de Woestijne A. P. Zwinderman A. H. Visseren F. L. J. Jukema J. W.

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1065-1068

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of adherence and tolerability of prolonged‐release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

Cardiology, Vol. 135, Iss. 1, 2016-05 ,pp. : 3-12

Karger

Access to resources Recommend Favorite